AI assistant
Zai Lab Ltd — Director's Dealing 2025
Mar 6, 2025
31208_dirs_2025-03-06_3ab96bf0-673b-47ea-9621-90fa2d648ec2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2025-03-04
Reporting Person: Du Ying (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-04 | American Depositary Shares | M | 50000 | $0.6 | Acquired | 544117 | Direct |
| 2025-03-04 | American Depositary Shares | S | 6665 | $32.6901 | Disposed | 537452 | Direct |
| 2025-03-04 | American Depositary Shares | S | 37752 | $33.55 | Disposed | 499700 | Direct |
| 2025-03-04 | American Depositary Shares | S | 5583 | $33.9859 | Disposed | 494117 | Direct |
| 2025-03-05 | American Depositary Shares | M | 46389 | $0.6 | Acquired | 540506 | Direct |
| 2025-03-05 | American Depositary Shares | S | 21093 | $35.1984 | Disposed | 519413 | Direct |
| 2025-03-05 | American Depositary Shares | S | 25296 | $35.8429 | Disposed | 494117 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | Stock Options (Right to Buy) | $0.6 | M | 50000 | Disposed | 2025-10-22 | American Depositary Shares (50000) | Direct |
| 2025-03-05 | Stock Options (Right to Buy) | $0.6 | M | 46389 | Disposed | 2025-10-22 | American Depositary Shares (46389) | Direct |
Footnotes
F1: Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.
F3: Reflects a weighted average sale price of $32.6901 per share, at prices ranging from $31.925 to $32.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: Reflects a weighted average sale price of $33.5500 per share, at prices ranging from $32.93 to $33.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5: Reflects a weighted average sale price of $33.9859 per share, at prices ranging from $33.93 to $34.07 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6: Reflects a weighted average sale price of $35.1984 per share, at prices ranging from $34.58 to $35.575 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F7: Reflects a weighted average sale price of $35.8429 per share, at prices ranging from $35.58 to $36.11 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F8: The Stock Options fully vested as of October 22, 2020.